RecruitingPhase 4NCT03416413

Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy

Randomised Controlled Trial of Foam Sclerotherapy Versus Ambulatory Phlebectomy for the Treatment of Varicose Vein Tributaries


Sponsor

Imperial College London

Enrollment

160 participants

Start Date

Feb 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be comparing the treatment of varicose vein tributaries using either foam sclerotherapy or ambulatory phlebectomies. Patients will be randomised to having either ambulatory phlebectomy (group A) or foam sclerotherapy (group B) following treatment of their saphenous vein. The re-intervention rates, safety, patient experience as well as the cost effectiveness of each intervention will be assessed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Ambulatory phlebectomy and a drug called Foam sclerotherapy for people with varicose veins. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAmbulatory phlebectomy

Minor surgery to remove varicose vein tributaries

DRUGFoam sclerotherapy

Injection of foam sclerosant into varicose vein tributaries


Locations(1)

Charing Cross Hospital, Imperial College London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03416413


Related Trials